Neutral
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ( "IPF" )
No decline in lung function observed at 6-week interim analysis builds upon positive safety and biomarker data ...